Core Viewpoint - The 2025 Eastsun Health Natural Beauty AI Technology and Health Industry New Product Strategy Launch Conference emphasizes the integration of AI technology with the beauty industry, aiming to lead a new era of health and beauty through innovative products and strategies [1][2][3]. Group 1: Company Strategy and Vision - Eastsun Health Natural Beauty aims to transition from a beauty industry benchmark to a century-long health ecosystem leader, focusing on the "AI Technology · Beauty Industry · All Health" strategy [3][4]. - The company plans to open 10,000 stores in the next three years as part of its "Centennial Coexistence Plan," emphasizing the importance of both consumer beauty and partner business success [3][4]. Group 2: Product Innovations - The launch of the second-generation NB-1 Diamond Peptide series and exclusive high-end care instruments like INDIBA White Moon reflects the company's commitment to merging beauty services with health management [4][5]. - New product lines include a comprehensive care loop covering facial, body, scalp care, and health foods, aligning with the national "Healthy China 2030" strategy [4][5]. Group 3: Industry Trends and Market Position - The beauty industry is evolving from a "beauty economy" to a "health economy," driven by consumer demand for health management and wellness services [4][6]. - Eastsun Health Natural Beauty is positioned as a leader in the beauty industry, with over 2,000 global stores and a focus on AI and biotechnology to enhance service offerings [3][4]. Group 4: Event Highlights and Engagement - The conference featured expert training sessions aimed at helping over a thousand store operators achieve significant sales milestones, showcasing the company's commitment to partner success [6]. - The event concluded with awards recognizing outstanding contributions within the company, reinforcing a culture of excellence and achievement [7].

在经济全球化浪潮中，中国始终坚定不移地扩大高水平对外开放。从中央经济工作会议提出"深化 外商投资促进体制机制改革""持续打造'投资中国'品牌"，到今年《政府工作报告》强调"扩大高 水平对外开放，积极稳外贸稳外资"，系列举措彰显出中国优化营商环境的坚定决心，也为外商投 资发展创造机遇。 3月2 1日，扎根中国超三十载的阿斯利康宣布2 5亿美元投资计划，在北京建立第六个全球战略 研发中心，并达成多项重大研发与生产合作，以进一步推动中国生命科学事业发展。 用实际行动为中国投下"信任票" 阿斯利康在欧洲和美国两大地区各设有两个战略研发中心，中国作为阿斯利康推动科学与创 新战略的重要组成部分，也迎来了新的里程碑——北京全球战略研发中心是继上海之后，阿 斯利康在中国建立的第二个全球战略研发中心。 图片说明：坐落于北京的阿斯利康全球战略研发中心 北京全球战略研发中心将以先进的人工智能和数据科学实验室为支撑，依托北京在前沿生物 学和人工智能科学领域的优势和创新生态，聚焦于癌症、心血管疾病、呼吸系统疾病、免疫 学以及人工智能应用等前沿领域的研究和开发。 同时，阿斯利康在北京将开展一系列新的研发合作，其中包括与北京大学肿瘤医院在 ...